US Broker Ratings

GH Research PLC (GHRS) Stock Analysis: A Biotech with 169% Potential Upside

GH Research PLC (NASDAQ: GHRS), a promising contender in the healthcare sector, specifically in biotechnology, offers a unique proposition for investors seeking exposure to innovative treatments..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: A Biotech with a 125% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) has been gaining attention in the biotech sector as a clinical-stage biopharmaceutical company that focuses on developing precision medicines for kidney..

Talkspace, Inc. (TALK) Stock Analysis: High Revenue Growth and a Promising 18.73% Potential Upside

Talkspace, Inc. (TALK), a prominent player in the virtual behavioral healthcare sector, is capturing investor attention with its robust revenue growth and significant potential upside. With..

AMN Healthcare Services Inc (AMN) Stock Analysis: Unlocking a Potential 22% Upside in the Healthcare Sector

AMN Healthcare Services Inc (AMN), a significant player in the healthcare staffing and workforce solutions sector, commands investor attention with its robust operational framework and promising..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating the 21.62% Potential Upside Amidst Challenges

Community Health Systems, Inc. (NYSE: CYH) is a significant player in the healthcare sector, specializing in medical care facilities across the United States. With a market..

Orthofix Medical Inc. (OFIX) Investor Outlook: Unveiling a 49.61% Upside Potential

Investors looking for opportunities in the medical device sector may find Orthofix Medical Inc. (NASDAQ: OFIX) an intriguing prospect. Headquartered in Lewisville, Texas, this healthcare company..

Inventiva S.A. (IVA): Analyst Ratings Signal Significant Upside Potential for Biotech Innovator

Inventiva S.A. (NASDAQ: IVA), a burgeoning player in the biotechnology sector, is capturing investor attention with its robust growth potential and promising pipeline. Headquartered in Daix,..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Potential Upside of Over 218% with a Focus on Kidney Disease Treatments

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is gaining attention from investors, particularly those interested in the healthcare sector’s drug manufacturing niche. As a biopharmaceutical company headquartered in..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Unveiling a 52.51% Potential Upside for Investors

Amylyx Pharmaceuticals, Inc. (AMLX), a Cambridge, Massachusetts-based clinical-stage pharmaceutical company, is making waves in the healthcare sector, specifically in the niche of drug manufacturers specializing in..

Arbutus Biopharma (ABUS) Stock Analysis: Evaluating a 25% Upside Potential in the Biotechnology Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of the biotechnology sector with its focus on developing innovative therapeutics for infectious diseases. Headquartered in Warminster,..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring Growth Potential and Analyst Consensus with a Promising 17.76% Upside

AxoGen, Inc. (AXGN) stands as a compelling player in the healthcare sector, specifically within the medical devices industry. As a company dedicated to the development and..

Nuvation Bio Inc. (NUVB) Stock Analysis: Explosive 162% Upside Potential Amid Robust Revenue Growth

Nuvation Bio Inc. (NASDAQ: NUVB), a burgeoning entity in the biotechnology sector, has captured investor attention with its remarkable 162% potential upside, offering a compelling narrative..

Claritev Corporation (CTEV) Stock Analysis: Exploring a 144.85% Potential Upside in Health Information Services

Claritev Corporation (NASDAQ: CTEV) offers an intriguing prospect for investors with a potential upside of 144.85% based on its average target price of $42.75. This healthcare-focused..

Immatics N.V. (IMTX) Stock Analysis: Exploring an 81% Upside in Cancer Immunotherapy

Immatics N.V. (NASDAQ: IMTX), a German biotechnology firm, is making waves in the healthcare sector with its innovative approach to cancer treatment. Specializing in T cell..

Akso Health Group (AHG) Stock Analysis: Navigating Through Challenges in the Healthcare Sector

Akso Health Group (NASDAQ: AHG), a prominent player in the healthcare sector in China, has been drawing attention with its distinctive approach to medical distribution and..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 136% Upside for Investors

Definitive Healthcare Corp. (NASDAQ: DH) operates within the dynamic Health Information Services industry, providing a comprehensive software-as-a-service (SaaS) healthcare commercial intelligence platform. With a market cap..

Tilray Brands, Inc. (TLRY): Investor Outlook on a Cannabis Leader with 70% Upside Potential

Tilray Brands, Inc. (NASDAQ: TLRY) has become a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Leamington,..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech with Nearly 99% Potential Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector. Specializing in the development of therapies for central nervous..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: 67.86% Upside Potential and Biotech Innovations

Capricor Therapeutics, Inc. (NASDAQ: CAPR) stands out in the biotechnology sector, offering promising avenues for investors seeking growth opportunities in groundbreaking medical treatments. Based in San..

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook Amidst a Potential 25.60% Upside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, has captured investor attention with a potential upside of 25.60%, despite facing significant..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds